ValuEngine lowered shares of Molina Healthcare (NYSE:MOH) from a hold rating to a sell rating in a research note issued to investors on Thursday morning, ValuEngine reports.
A number of other equities research analysts also recently weighed in on the stock. BMO Capital Markets raised shares of Molina Healthcare from a market perform rating to an outperform rating and boosted their price objective for the company from $154.00 to $200.00 in a research report on Monday, June 3rd. Morgan Stanley boosted their price objective on shares of Molina Healthcare from $178.00 to $184.00 and gave the company an overweight rating in a research report on Friday, July 12th. Barclays boosted their price objective on shares of Molina Healthcare from $140.00 to $149.00 and gave the company an equal weight rating in a research report on Friday, May 31st. Wells Fargo & Co raised shares of Molina Healthcare from a market perform rating to an outperform rating and set a $177.00 price objective for the company in a research report on Friday, May 31st. Finally, Bank of America reaffirmed an underperform rating and set a $140.00 price objective (up previously from $132.00) on shares of Molina Healthcare in a research report on Wednesday. Two analysts have rated the stock with a sell rating, five have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of Hold and a consensus price target of $162.82.
Shares of Molina Healthcare stock traded down $1.00 during trading on Thursday, reaching $129.24. The company had a trading volume of 480,916 shares, compared to its average volume of 492,433. The firm has a market capitalization of $8.16 billion, a P/E ratio of 11.66, a price-to-earnings-growth ratio of 1.18 and a beta of 1.25. The firm’s fifty day simple moving average is $141.94. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.57 and a current ratio of 1.73. Molina Healthcare has a fifty-two week low of $105.28 and a fifty-two week high of $159.00.
Molina Healthcare (NYSE:MOH) last issued its earnings results on Tuesday, July 30th. The company reported $3.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.56 by $0.55. The business had revenue of $4.19 billion for the quarter, compared to analyst estimates of $4.08 billion. Molina Healthcare had a net margin of 4.48% and a return on equity of 51.49%. The company’s revenue for the quarter was down 14.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.08 EPS. On average, equities analysts forecast that Molina Healthcare will post 11.48 EPS for the current fiscal year.
In other Molina Healthcare news, Director Daniel Cooperman sold 4,004 shares of the company’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $155.00, for a total value of $620,620.00. Following the completion of the transaction, the director now owns 4,096 shares in the company, valued at approximately $634,880. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the company’s stock in a transaction dated Wednesday, May 8th. The stock was sold at an average price of $126.30, for a total transaction of $126,300.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,304 shares of company stock valued at $945,495. Insiders own 0.77% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Parallel Advisors LLC grew its position in Molina Healthcare by 97.9% in the 1st quarter. Parallel Advisors LLC now owns 186 shares of the company’s stock worth $26,000 after purchasing an additional 92 shares during the last quarter. Cornerstone Advisors Inc. grew its position in Molina Healthcare by 3,577.8% in the 1st quarter. Cornerstone Advisors Inc. now owns 331 shares of the company’s stock worth $47,000 after purchasing an additional 322 shares during the last quarter. FTB Advisors Inc. grew its position in Molina Healthcare by 367.6% in the 1st quarter. FTB Advisors Inc. now owns 346 shares of the company’s stock worth $48,000 after purchasing an additional 272 shares during the last quarter. Financial Gravity Wealth Inc. bought a new position in Molina Healthcare in the 1st quarter worth about $54,000. Finally, Quadrant Capital Group LLC grew its position in Molina Healthcare by 289.3% in the 1st quarter. Quadrant Capital Group LLC now owns 545 shares of the company’s stock worth $71,000 after purchasing an additional 405 shares during the last quarter. Hedge funds and other institutional investors own 99.94% of the company’s stock.
Molina Healthcare Company Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: Diluted Earnings Per Share
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.